# AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

> **NCT07158905** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Institute for Molecular Medicine** · enrollment: 48 (estimated)

## Conditions studied

- Alzheimer Disease
- Preclinical Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** AV-1980R 20 µg
- **BIOLOGICAL:** AV-1980R 60 µg
- **BIOLOGICAL:** AV-1980R 180 µg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07158905
- **Lead sponsor:** Institute for Molecular Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2029-06-15
- **Final completion:** 2029-10-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07158905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07158905, "AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07158905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*